In last trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 0.55 million shares changing hands with its beta currently measuring 0.53. Company’s recent per share price
Relmada Therapeutics Inc (NASDAQ:RLMD) has a beta value of 0.53 and has seen 1.27 million shares traded in the last trading session. The company, currently
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 2.45 million, with the beta value of the company hitting 0.50. At the end
In the last trading session, 3.31 million shares of the Relmada Therapeutics Inc (NASDAQ:RLMD) were traded, and its beta was 0.45. Most recently the company’s
In the last trading session, 1.24 million shares of the Relmada Therapeutics Inc (NASDAQ:RLMD) were traded, and its beta was 0.39. Most recently the company’s
In last trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 0.42 million shares changing hands with its beta currently measuring 0.54. Company’s recent per share price
Relmada Therapeutics Inc (NASDAQ:RLMD) has a beta value of 0.38 and has seen 1.26 million shares traded in the last trading session. The company, currently
Relmada Therapeutics Inc (NASDAQ:RLMD) has a beta value of 0.38 and has seen 0.72 million shares traded in the recent trading session. The company, currently
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 3.01 million, with the beta value of the company hitting 0.35. At the end
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 1.5 million, with the beta value of the company hitting 0.39. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
